清醒俯卧位对covid-19相关低氧性呼吸衰竭患者的疗效:随机试验的系统评价与Meta分析
该系统评价与Meta分析纳入17项随机试验共2931例covid-19相关低氧性呼吸衰竭的未插管成人,比较清醒俯卧位与常规治疗。主要结局气管插管风险降低(粗率24.2% vs 29.8%,RR 0.83,95%CI 0.73–0.94,高确定性),相当于每1000例患者减少55次插管(95%CI 减少87至19次)。死亡率(15.6% vs 17.2%,RR 0.90,0.76–1.07,高确定性)、无呼吸机天数、ICU住院时间、住院时间及氧疗升级等次要结局均无显著差异。与清醒俯卧位相关的不良事件不常见。贝叶斯Meta分析显示清醒俯卧位对气管插管获益概率高,对死亡率获益概率较低。
要点
- 在covid-19相关低氧性呼吸衰竭的未插管成人中,清醒俯卧位较常规治疗降低气管插管风险:粗率24.2% vs 29.8%,RR 0.83(95%CI 0.73–0.94),高确定性。
- 气管插管风险的绝对效应为每1000例患者减少55次插管(95%CI 减少87至19次)。
- 清醒俯卧位对死亡率无显著影响:15.6% vs 17.2%,RR 0.90(95%CI 0.76–1.07),高确定性。
- 无呼吸机天数(均差0.97天,95%CI -0.5至3.4,低确定性)、ICU住院时间(-2.1天,95%CI -4.5至0.4,低确定性)、住院时间(-0.09天,95%CI -0.69至0.51,中等确定性)及氧疗升级(21.4% vs 23.0%,RR 1.04,95%CI 0.74–1.44,低确定性)均无显著差异。
- 贝叶斯Meta分析:气管插管获益的后验概率为RR<0.95达96%(均值RR 0.83,95%可信区间0.70–0.97);死亡率的后验概率为RR<0.95仅68%(均值0.90,95%可信区间0.73–1.13)。
适用人群与场景
- covid-19相关低氧性呼吸衰竭的未插管成人(非插管患者),比较清醒俯卧位与常规治疗。
研究设计与关键结果
- 系统评价与Meta分析,共纳入17项随机试验、2931例患者;12项试验为低偏倚风险,3项有一些担忧,2项为高偏倚风险。
- 主要结局气管插管:清醒俯卧位组粗率24.2% vs 常规治疗组29.8%,RR 0.83(95%CI 0.73–0.94),高确定性;绝对效应为每1000例患者减少55次插管(95%CI 减少87至19次)。
- 死亡率:15.6% vs 17.2%,RR 0.90(95%CI 0.76–1.07),高确定性,无显著差异。
- 无呼吸机天数:均差0.97天(95%CI -0.5至3.4),低确定性,无显著差异。
- ICU住院时间:均差-2.1天(95%CI -4.5至0.4),低确定性,无显著差异。
- 住院时间:均差-0.09天(95%CI -0.69至0.51),中等确定性,无显著差异。
- 氧疗升级:21.4% vs 23.0%,RR 1.04(95%CI 0.74–1.44),低确定性,无显著差异。
- 与清醒俯卧位相关的不良事件不常见。
证据类型、等级与局限
- 证据类型:随机试验的系统评价与Meta分析(频率学派及贝叶斯Meta分析),采用GRADE分级评估证据确定性。
- 主要结局气管插管为高确定性证据;死亡率为高确定性;住院时间为中等确定性;无呼吸机天数、ICU住院时间及氧疗升级为低确定性。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于covid-19相关低氧性呼吸衰竭的未插管成人,清醒俯卧位可降低气管插管风险(每1000例减少55次插管),但对死亡率、无呼吸机天数、ICU及住院时间、氧疗升级可能几乎无影响。
- 与清醒俯卧位相关的不良事件不常见。
指南或共识出处
- PROSPERO注册号CRD42022314856。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the efficacy and safety of awake prone positioning versus usual care in non-intubated adults with hypoxemic respiratory failure due to covid-19.
DESIGN: Systematic review with frequentist and bayesian meta-analyses.
STUDY ELIGIBILITY: Randomized trials comparing awake prone positioning versus usual care in adults with covid-19 related hypoxemic respiratory failure. Information sources were Medline, Embase, and the Cochrane Central Register of Controlled Trials from inception to 4 March 2022.
DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted data and assessed risk of bias. Random effects meta-analyses were performed for the primary and secondary outcomes. Bayesian meta-analyses were performed for endotracheal intubation and mortality outcomes. GRADE certainty of evidence was assessed for outcomes.
MAIN OUTCOME MEASURES: The primary outcome was endotracheal intubation. Secondary outcomes were mortality, ventilator-free days, intensive care unit (ICU) and hospital length of stay, escalation of oxygen modality, change in oxygenation and respiratory rate, and adverse events.
RESULTS: 17 trials (2931 patients) met the eligibility criteria. 12 trials were at low risk of bias, three had some concerns, and two were at high risk. Awake prone positioning reduced the risk of endotracheal intubation compared with usual care (crude average 24.2% v 29.8%, relative risk 0.83, 95% confidence interval 0.73 to 0.94; high certainty). This translates to 55 fewer intubations per 1000 patients (95% confidence interval 87 to 19 fewer intubations). Awake prone positioning did not significantly affect secondary outcomes, including mortality (15.6% v 17.2%, relative risk 0.90, 0.76 to 1.07; high certainty), ventilator-free days (mean difference 0.97 days, 95% confidence interval -0.5 to 3.4; low certainty), ICU length of stay (-2.1 days, -4.5 to 0.4; low certainty), hospital length of stay (-0.09 days, -0.69 to 0.51; moderate certainty), and escalation of oxygen modality (21.4% v 23.0%, relative risk 1.04, 0.74 to 1.44; low certainty). Adverse events related to awake prone positioning were uncommon. Bayesian meta-analysis showed a high probability of benefit with awake prone positioning for endotracheal intubation (non-informative prior, mean relative risk 0.83, 95% credible interval 0.70 to 0.97; posterior probability for relative risk <0.95=96%) but lower probability for mortality (0.90, 0.73 to 1.13; <0.95=68%).
CONCLUSIONS: Awake prone positioning compared with usual care reduces the risk of endotracheal intubation in adults with hypoxemic respiratory failure due to covid-19 but probably has little to no effect on mortality or other outcomes.
SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42022314856.
参考来源
- Weatherald J, Parhar KKS, Al Duhailib Z, et al. Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure: systematic review and meta-analysis of randomized trials. BMJ. 2022. PMID: 36740866. doi:10.1136/bmj-2022-071966
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。